%0 Journal Article
%T BMS-986163, a Negative Allosteric Modulator of GluN2B
with Potential Utility in Major Depressive Disorder
%A Alicia Ng
%A Aliphedi B. Reddy
%A Arvind Mathur
%A Bettadapura N. Srikumar
%A Bradley C. Pearce
%A Charlie Albright
%A Charulatha Sanmathi
%A Dalton King
%A Eric Shields
%A G. Nagaraju
%A George N. Karageorge
%A Gopikishan Tonukunuru
%A Grandhi V. R.
K. M. Gupta
%A Huiping Zhang
%A Hyunsoo Park
%A Imadul Islam
%A James Kempson
%A Jayakumar Warrier
%A Jayant Aher
%A Jean Simmermacher
%A Jianliang Shi
%A Jianqing Li
%A Joanne J. Bronson
%A John E. Macor
%A Jyoti Gulia
%A Kumar Kuchibhotla Vijaya
%A Lawrence R. Marcin
%A Linda J. Bristow
%A Lorin A. Thompson
%A Mahesh Paschapur
%A Manjunath Ramarao
%A Manjunatha Kamble
%A Michael Sinz
%A Michelle Nophsker
%A Murali Subramanian
%A Narasimharaju Kalidindi
%A Pattipati S. Naidu
%A Rajareddy Kallem
%A Raju Mannoori
%A Reeba Vikramadithyan
%A Rex Denton
%A Richard E. Olson
%A Srinivas Cheruku
%A Srinivas Jogi
%A Srinivasan Thangathirupathy
%A Tanmaya Bastia
%A Thaddeus Molski
%A Xiaoliang Zhuo
%J Archive of "ACS Medicinal Chemistry Letters".
%D 2018
%R 10.1021/acsmedchemlett.8b00080
%K BMS-986163
%K BMS-986169
%K GluN2B
%K negative allosteric modulator
%K ketamine
%K depression
%K preclinical candidate
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949833/